Macrophage migration inhibitory factor mediates proliferative GN via CD74

Journal of the American Society of Nephrology

Volumn 27, Issue 6, 2016, Pages 1650-1664

  Djudjaj, Sonja ^a   Lue, Hongqi ^a   Rong, Song ^a   Papasotiriou, Marios ^a   Klinkhammer, Barbara M ^a   Zok, Stephanie ^a   Klaener, Ole ^a   Braun, Gerald S ^a   Lindenmeyer, Maja T ^b   Cohen, Clemens D ^b   Bucala, Richard ^c   Tittel, Andre P ^d   Kurts, Christian ^d   Moeller, Marcus J ^a   Floege, Juergen ^a   Ostendorf, Tammo ^a   Bernhagen, Jürgen ^a   Boor, Peter ^a,e  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF BONN   (Germany)

^e Physics and Informatics   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

CD74 ANTIGEN; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR4; CREATININE; CYCLINE; DOXORUBICIN; HERMES ANTIGEN; KI 67 ANTIGEN; MACROPHAGE MIGRATION INHIBITION FACTOR; MESSENGER RNA; NITROGEN; UREA; B LYMPHOCYTE ANTIGEN; HLA ANTIGEN CLASS 2; INVARIANT CHAIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL INFILTRATION; CELL MEMBRANE; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; GLOMERULONEPHRITIS; GLOMERULOPATHY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MESANGIUM CELL; MIDDLE AGED; MITOGENESIS; MOUSE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEINURIA; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEADY STATE; UPREGULATION; UREA NITROGEN BLOOD LEVEL; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CELL CULTURE; CYTOLOGY; GLOMERULUS; PATHOLOGY; PHYSIOLOGY;

ANIMALS; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; GLOMERULONEPHRITIS; HISTOCOMPATIBILITY ANTIGENS CLASS II; KIDNEY GLOMERULUS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MICE; MICE, INBRED C57BL;

EID: 85011743819     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2015020149     Document Type: Article

References (69)

1. Bendrat K, Al-Abed Y, Callaway DJ, Peng T, Calandra T, Metz CN, Bucala R: Biochemical and mutational investigations of the enzymatic activity of macrophage migration inhibitory factor. Biochemistry 36: 15356-15362, 1997
2. Bernhagen J, Calandra T,Mitchell RA,Martin SB, Tracey KJ, VoelterW, Manogue KR, Cerami A, Bucala R: MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 365: 756-759, 1993
3. Bernhagen J, Krohn R, Lue H, Gregory JL, Zernecke A, Koenen RR, Dewor M,Georgiev I, SchoberA, Leng L, Kooistra T, Fingerle-RowsonG,Ghezzi P, Kleemann R, McColl SR, Bucala R, Hickey MJ, Weber C: MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med 13: 587-596, 2007
4. Kleemann R, Hausser A, Geiger G, Mischke R, Burger-Kentischer A, Flieger O, Johannes FJ, Roger T, Calandra T, Kapurniotu A, Grell M, Finkelmeier D, Brunner H, Bernhagen J: Intracellular action of the cytokineMIF to modulate AP-1 activity and the cell cycle through Jab1. Nature 408: 211-216, 2000
5. Mitchell RA, Bucala R: Tumor growth-promoting properties of macrophage migration inhibitory factor (MIF). Semin Cancer Biol 10: 359-366, 2000
6. Morand EF, Bucala R, Leech M: Macrophage migration inhibitory factor: an emerging therapeutic target in rheumatoid arthritis. Arthritis Rheum 48: 291-299, 2003
7. Leng L, Metz CN, Fang Y, Xu J, Donnelly S, Baugh J, Delohery T, Chen Y,Mitchell RA, Bucala R:MIF signal transduction initiated by binding to CD74. J ExpMed 197: 1467-1476, 2003
8. Sanchez-Nino MD, Sanz AB, Ruiz-Andres O, Poveda J, Izquierdo MC, Selgas R, Egido J, Ortiz A: MIF, CD74 and other partners in kidney disease: tales of a promiscuous couple.CytokineGrowth Factor Rev 24: 23-40, 2013
9. Starlets D, Gore Y, Binsky I, Haran M, Harpaz N, Shvidel L, Becker-Herman S, Berrebi A, Shachar I: Cell-surface CD74 initiates a signaling cascade leading to cell proliferation and survival. Blood 107: 4807-4816, 2006
10. Lan HY, Mu W, Yang N, Meinhardt A, Nikolic-Paterson DJ, Ng YY, Bacher M, Atkins RC, Bucala R: De Novo renal expression of macrophage migration inhibitory factor during the development of rat crescentic glomerulonephritis. Am J Pathol 149: 1119-1127, 1996
11. Leung JC, Chan LY, Tsang AW, Liu EW, LamMF, Tang SC, Lai KN: Antimacrophage migration inhibitory factor reduces transforming growth factor-beta 1 expression in experimental IgA nephropathy. Nephrol Dial Transplant 19: 1976-1985, 2004
12. Hoi AY, Hickey MJ, Hall P, Yamana J, O'Sullivan KM, Santos LL, James WG, Kitching AR, Morand EF: Macrophage migration inhibitory factor deficiency attenuates macrophage recruitment, glomerulonephritis, and lethality in MRL/lpr mice. J Immunol 177: 5687-5696, 2006
13. Lan HY, Bacher M, Yang N, Mu W, Nikolic-Paterson DJ, Metz C, Meinhardt A, Bucala R, Atkins RC: The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat. J ExpMed 185: 1455-1465, 1997
14. Yang N, Nikolic-Paterson DJ, Ng YY, Mu W, Metz C, Bacher M, Meinhardt A, Bucala R, Atkins RC, Lan HY: Reversal of established rat crescentic glomerulonephritis by blockade of macrophage migration inhibitory factor (MIF): potential role ofMIF in regulating glucocorticoid production. Mol Med 4: 413-424, 1998
15. Leng L, Chen L, Fan J, Greven D, Arjona A, Du X, Austin D, Kashgarian M, Yin Z, Huang XR, Lan HY, Lolis E, Nikolic-Paterson D, Bucala R: A small-molecule macrophage migration inhibitory factor antagonist protects against glomerulonephritis in lupus-prone NZB/NZW F1 and MRL/lpr mice. J Immunol 186: 527-538, 2011
16. Sanchez-Niño MD, Sanz AB, Ihalmo P, Lassila M, Holthofer H, Mezzano S, Aros C, Groop PH, Saleem MA, Mathieson PW, Langham R, Kretzler M, Nair V, Lemley KV, Nelson RG, Mervaala E,Mattinzoli D, RastaldiMP, Ruiz-Ortega M, Martin-Ventura JL, Egido J, Ortiz A: The MIF receptor CD74 in diabetic podocyte injury. J Am SocNephrol 20: 353-362, 2009
17. Sicking EM, Fuss A, Uhlig S, Jirak P, Dijkman H, Wetzels J, Engel DR, Urzynicok T, Heidenreich S, Kriz W, Kurts C, Ostendorf T, Floege J, Smeets B, Moeller MJ: Subtotal ablation of parietal epithelial cells induces crescent formation. J Am Soc Nephrol 23: 629-640, 2012
18. Smeets B, Uhlig S, Fuss A,Mooren F,Wetzels JF, Floege J, MoellerMJ: Tracing the origin of glomerular extracapillary lesions from parietal epithelial cells. J Am Soc Nephrol 20: 2604-2615, 2009
19. Smeets B, Stucker F, Wetzels J, Brocheriou I, Ronco P, Gröne HJ, D'Agati V, Fogo AB, van Kuppevelt TH, Fischer HP, Boor P, Floege J, Ostendorf T,Moeller MJ: Detection of activated parietal epithelial cells on the glomerular tuft distinguishes early focal segmental glomerulosclerosis from minimal change disease. Am J Pathol 184: 3239-3248, 2014
20. Roberts IS, Cook HT, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, Cattran DC, Coppo R, D'Agati V, D'Amico G, Emancipator S, Emma F, Feehally J, Ferrario F, Fervenza FC, Florquin S, Fogo A, Geddes CC, Groene HJ, Haas M, Herzenberg AM, Hill PA, Hogg RJ, Hsu SI, Jennette JC, Joh K, Julian BA, Kawamura T, Lai FM, Li LS, Li PK, Liu ZH, Mackinnon B, Mezzano S, Schena FP, Tomino Y, Walker PD, Wang H, Weening JJ, Yoshikawa N, Zhang H; Working Group of the International IgA Nephropathy Network and the Renal Pathology Society: TheOxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int 76: 546-556, 2009
21. Jennette JC, Olson JL, Silva FG, D'Agati V: Heptinstall's Pathology of the Kidney, Philadelphia, PA, Lippincott Williams & Wilkins, 2014
22. Smeets B, Angelotti ML, Rizzo P, Dijkman H, Lazzeri E, Mooren F, Ballerini L, Parente E, Sagrinati C, Mazzinghi B, Ronconi E, Becherucci F, Benigni A, Steenbergen E, Lasagni L, Remuzzi G, Wetzels J, Romagnani P: Renal progenitor cells contribute to hyperplastic lesions of podocytopathies and crescentic glomerulonephritis. J Am Soc Nephrol 20: 2593-2603, 2009
23. Fatima H, Moeller MJ, Smeets B, Yang HC, D'Agati VD, Alpers CE, Fogo AB: Parietal epithelial cell activation marker in early recurrence of FSGS in the transplant. Clin J Am Soc Nephrol 7: 1852-1858, 2012
24. Shankland SJ, Smeets B, Pippin JW,MoellerMJ: The emergence of the glomerular parietal epithelial cell. Nat Rev Nephrol 10: 158-173, 2014
25. Bariéty J, Bruneval P,Meyrier A,Mandet C, HillG, Jacquot C: Podocyte involvement in human immune crescentic glomerulonephritis. Kidney Int 68: 1109-1119, 2005
26. Moeller MJ, Soofi A, Hartmann I, Le Hir M,Wiggins R, Kriz W, Holzman LB: Podocytes populate cellular crescents in a murine model of inflammatory glomerulonephritis. J Am Soc Nephrol 15: 61-67, 2004
27. Lan HY: Role of macrophage migration inhibitory factor in kidney diseases. Nephron, Exp Nephrol 109: 79-83, 2008
28. Tesch GH, Nikolic-Paterson DJ, Metz CN, Mu W, Bacher M, Bucala R, Atkins RC, Lan HY: Rat mesangial cells express macrophage migration inhibitory factor in vitro and in vivo. J AmSoc Nephrol 9: 417-424, 1998
29. Nikolic-Paterson DJ, Jun Z, Tesch GH, Lan HY, Foti R, Atkins RC: De novo CD44 expression by proliferatingmesangial cells in rat anti-Thy-1 nephritis. J Am Soc Nephrol 7: 1006-1014, 1996
30. Jun Z, Hill PA, Lan HY, Foti R, Mu W, Atkins RC, Nikolic-Paterson DJ: CD44 and hyaluronan expression in the development of experimental crescentic glomerulonephritis. Clin Exp Immunol 108: 69-77, 1997
31. Kabgani N, Grigoleit T, Schulte K, Sechi A, Sauer-Lehnen S, Tag C, Boor P, Kuppe C, Warsow G, Schordan S, Mostertz J, Chilukoti RK, Homuth G, Endlich N, Tacke F, Weiskirchen R, Fuellen G, Endlich K, Floege J, Smeets B,MoellerMJ: Primary cultures of glomerular parietal epithelial cells or podocytes with proven origin. PLoS One 7: e34907, 2012
32. Hanssen L, Alidousty C, Djudjaj S, Frye BC, Rauen T, Boor P, Mertens PR, van Roeyen CR, Tacke F, Heymann F, Tittel AP, Koch A, Floege J, Ostendorf T, Raffetseder U: YB-1 is an early and central mediator of bacterial and sterile inflammation in vivo. J Immunol 191: 2604-2613, 2013
33. Cortes-Hernandez J, Fossati-Jimack L, Carugati A, Potter PK, Walport MJ, Cook HT, Botto M: Murine glomerular mesangial cell uptake of apoptotic cells is inefficient and involves serum-mediated but complement-independent mechanisms. Clin Exp Immunol 130: 459-466, 2002
34. Heinrichs D, Knauel M, Offermanns C, Berres ML, Nellen A, Leng L, Schmitz P, Bucala R, Trautwein C, Weber C, Bernhagen J,Wasmuth HE: Macrophage migration inhibitory factor (MIF) exerts antifibrotic effects in experimental liver fibrosis via CD74. Proc Natl Acad Sci U S A 108: 17444-17449, 2011
35. Gore Y, StarletsD,Maharshak N, Becker-Herman S, Kaneyuki U, Leng L, Bucala R, Shachar I: Macrophage migration inhibitory factor induces B cell survival by activation of a CD74-CD44 receptor complex. J Biol Chem 283: 2784-2792, 2008
36. Moeller MJ, Smeets B: Novel target in the treatment of RPGN: The activated parietal cell. Nephrol Dial Transplant 28: 489-492, 2013
37. Smeets B, Kuppe C, Sicking EM, Fuss A, Jirak P, van Kuppevelt TH, Endlich K, Wetzels JF, Gröne HJ, Floege J, Moeller MJ: Parietal epithelial cells participate in the formation of sclerotic lesions in focal segmental glomerulosclerosis. J AmSocNephrol 22: 1262-1274, 2011
38. Boor P, Ostendorf T, Floege J: PDGF and the progression of renal disease. Nephrol Dial Transplant 29[Suppl 1]: i45-i54, 2014
39. Floege J, BurnsMW, Alpers CE, Yoshimura A, Pritzl P,Gordon K, Seifert RA, Bowen-Pope DF, Couser WG, Johnson RJ: Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int 41: 297-309, 1992
40. Floege J, Eitner F, Van Roeyen C, Ostendorf T: PDGF-D and renal disease: yet another one of those growth factors?JAmSocNephrol 14: 2690-2691, 2003
41. Floege J, van Roeyen C, Boor P, Ostendorf T: The role of PDGF-D in mesangioproliferative glomerulonephritis. Contrib Nephrol 157: 153-158, 2007
42. Schrans-Stassen BH, Lue H, Sonnemans DG, Bernhagen J, Post MJ: Stimulation of vascular smooth muscle cell migration by macrophage migration inhibitory factor. Antioxid Redox Signal 7: 1211-1216, 2005
43. Ohta S,Misawa A, Fukaya R, Inoue S, Kanemura Y,Okano H, Kawakami Y, TodaM:Macrophagemigration inhibitory factor (MIF) promotes cell survival and proliferation of neural stem/progenitor cells.JCell Sci 125: 3210-3220, 2012
44. Lim S, Choong LY, Kuan CP, Yunhao C, Lim YP: Regulation of macrophage inhibitory factor (MIF) by epidermal growth factor receptor (EGFR) in the MCF10AT model of breast cancer progression. J Proteome Res 8: 4062-4076, 2009
45. Martín-Ventura JL, Madrigal-Matute J, Muñoz-Garcia B, Blanco-Colio LM, VanOostromM, Zalba G, Fortuño A,Gomez-Guerrero C, Ortega L, Ortiz A, Diez J, Egido J: Increased CD74 expression in human atherosclerotic plaques: contribution to inflammatory responses in vascular cells. Cardiovasc Res 83: 586-594, 2009
46. Shachar I, Flavell RA: Requirement for invariant chain in B cell maturation and function. Science 274: 106-108, 1996
47. Bernhagen J, Calandra T, Bucala R: Regulation of the immune response by macrophage migration inhibitory factor: biological and structural features. J MolMed (Berl) 76: 151-161, 1998
48. Calandra T, Roger T: Macrophage migration inhibitory factor: A regulator of innate immunity. Nat Rev Immunol 3: 791-800, 2003
49. Calandra T, Spiegel LA,MetzCN, Bucala R: Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of Gram-positive bacteria. Proc Natl Acad Sci U S A 95: 11383-11388, 1998
50. Simons D, Grieb G, Hristov M, Pallua N, Weber C, Bernhagen J, Steffens G: Hypoxia-induced endothelial secretion of macrophage migration inhibitory factor and role in endothelial progenitor cell recruitment. J Cell Mol Med 15: 668-678, 2011
51. Strüßmann T, Tillmann S, Wirtz T, Bucala R, von Hundelshausen P, Bernhagen J: Platelets are a previously unrecognised source of MIF. Thromb Haemost 110: 1004-1013, 2013
52. Rice EK, Tesch GH, Cao Z, Cooper ME, Metz CN, Bucala R, Atkins RC, Nikolic-Paterson DJ: Induction of MIF synthesis and secretion by tubular epithelial cells: A novel action of angiotensin II. Kidney Int 63: 1265-1275, 2003
53. Flieger O, Engling A, Bucala R, Lue H, Nickel W, Bernhagen J: Regulated secretion of macrophage migration inhibitory factor is mediated by a non-classical pathway involving an ABC transporter. FEBS Lett 551: 78-86, 2003
54. Leung JC, Tang SC, Chan LY, TsangAW, Lan HY, Lai KN: Polymeric IgA increases the synthesis of macrophage migration inhibitory factor by human mesangial cells in IgA nephropathy. Nephrol Dial Transplant 18: 36-45, 2003
55. Smeets B, Te Loeke NA, Dijkman HB, Steenbergen ML, Lensen JF, Begieneman MP, van Kuppevelt TH, Wetzels JF, Steenbergen EJ: The parietal epithelial cell: A key player in the pathogenesis of focal segmental glomerulosclerosis in Thy-1.1 transgenic mice. J Am Soc Nephrol 15: 928-939, 2004
56. Shi X, Leng L, Wang T, Wang W, Du X, Li J, McDonald C, Chen Z, Murphy JW, Lolis E, Noble P, Knudson W, Bucala R: CD44 is the signaling component of themacrophagemigration inhibitory factor-CD74 receptor complex. Immunity 25: 595-606, 2006
57. Sasaki S, Nishihira J, Ishibashi T, Yamasaki Y, Obikane K, Echigoya M, Sado Y, Ninomiya Y, Kobayashi K: Transgene of MIF induces podocyte injury and progressive mesangial sclerosis in themouse kidney. Kidney Int 65: 469-481, 2004
58. Cohen CD, Lindenmeyer MT, Eichinger F, Hahn A, Seifert M, Moll AG, Schmid H, Kiss E, Gröne E, Gröne HJ, Kretzler M,Werner T, Nelson PJ: Improved elucidation of biological processes linked to diabetic nephropathy by single probe-based microarray data analysis. PLoS One 3: e2937, 2008
59. Cohen CD, Kretzler M: Gene expression analysis in microdissected renal tissue. Current challenges and strategies. Nephron 92: 522-528, 2002
60. Harper JM, Wilkinson JE, Miller RA: Macrophage migration inhibitory factor-knockout mice are long lived and respond to caloric restriction. FASEB J 24: 2436-2442, 2010
61. Bozza M, Satoskar AR, Lin G, Lu B, Humbles AA, Gerard C, David JR: Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J ExpMed 189: 341-346, 1999
62. Satoskar AR, Bozza M, Rodriguez Sosa M, Lin G, David JR: Migrationinhibitory factor gene-deficient mice are susceptible to cutaneous Leishmania major infection. Infect Immun 69: 906-911, 2001
63. Liehn EA, Kanzler I, Konschalla S, Kroh A, Simsekyilmaz S, Sönmez TT, Bucala R, Bernhagen J, Weber C: Compartmentalized protective and detrimental effects of endogenous macrophage migration-inhibitory factor mediated by CXCR2 in a mouse model of myocardial ischemia/reperfusion. Arterioscler Thromb Vasc Biol 33: 2180-2186, 2013
64. Wang X, Chen T, Leng L, Fan J, Cao K, Duan Z, Zhang X, Shao C,WuM, Tadmori I, Li T, Liang L, Sun D, Zheng S,Meinhardt A, YoungW, Bucala R, Ren Y: MIF produced by bone marrow-derived macrophages contributes to teratoma progression after embryonic stem cell transplantation. Cancer Res 72: 2867-2878, 2012
65. Zernecke A, Schober A, Bot I, von Hundelshausen P, Liehn EA, Möpps B, MericskayM, Gierschik P, Biessen EA, Weber C: SDF-1alpha/CXCR4 axis is instrumental in neointimal hyperplasia and recruitment of smooth muscle progenitor cells. Circ Res 96: 784-791, 2005
66. Boor P, Konieczny A, Villa L, Kunter U, van Roeyen CR, LaRochelle WJ, Smithson G, Arrol S, Ostendorf T, Floege J: PDGF-D inhibition by CR002 ameliorates tubulointerstitial fibrosis following experimental glomerulonephritis. Nephrol Dial Transplant 22: 1323-1331, 2007
67. Djudjaj S, Chatziantoniou C, Raffetseder U, Guerrot D, Dussaule JC, Boor P, KerrochM, Hanssen L, Brandt S, Dittrich A,Ostendorf T, Floege J, Zhu C, Lindenmeyer M, Cohen CD, Mertens PR: Notch-3 receptor activation drives inflammation and fibrosis following tubulointerstitial kidney injury. J Pathol 228: 286-299, 2012
68. Eitner F, Bücher E, van Roeyen C, Kunter U, Rong S, Seikrit C, Villa L, Boor P, Fredriksson L, Bäckström G, Eriksson U, Ostman A, Floege J, Ostendorf T: PDGF-C is a proinflammatory cytokine that mediates renal interstitial fibrosis. J AmSoc Nephrol 19: 281-289, 2008
69. Ostendorf T, Rong S, Boor P, Wiedemann S, Kunter U, Haubold U, van Roeyen CR, Eitner F, Kawachi H, StarlingG, Alvarez E, Smithson G, Floege J: Antagonism ofPDGF-D by human antibodyCR002 prevents renal scarring in experimental glomerulonephritis. J AmSocNephrol 17: 1054-1062, 2006